Penn researchers use AI to flag underreported side effects discussed by GLP‑1 drug users

6abc Philadelphia 6abc Philadelphia —

PHILADELPHIA - A new study from the University of Pennsylvania suggests that artificial intelligence may help identify potential side effects of popular GLP‑1 weight‑loss drugs that are being discussed online, but may not appear in clinical trial data.

Read full article at 6abc Philadelphia →